The Utility of Treatment With Nasogastric Tube Placement for Small Bowel Obstruction
Launched by DANIEL WILHELMS · Feb 13, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into the use of nasogastric tubes for patients with small bowel obstruction (SBO). SBO happens when something blocks the normal movement of the small intestine, often due to previous surgeries. While doctors typically use nasogastric tubes to help relieve pain and manage the condition, there is ongoing debate about whether this treatment is really beneficial for all patients. The trial aims to gather more evidence about the effectiveness of nasogastric tubes and how frailty—a state of increased vulnerability—might affect outcomes in older adults with SBO.
To participate in this study, individuals must be at least 18 years old and have been diagnosed with a small bowel obstruction. However, those who have had abdominal surgery in the past week or cannot provide informed consent will not be eligible. Participants can expect to contribute to important research that may change how SBO is treated, especially in older patients who are more at risk for complications. As the trial is currently recruiting, it represents an opportunity to be involved in a study that aims to improve patient care for this common condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed small bowel obstruction
- • Age 18 or older
- Exclusion Criteria:
- • Abdominal surgery within 7 days
- • Not able to give informed consent
About Daniel Wilhelms
Daniel Wilhelms is a dedicated clinical trial sponsor focused on advancing medical research and improving patient outcomes through innovative study designs and rigorous scientific methodologies. With a commitment to ethical standards and regulatory compliance, Wilhelms collaborates with healthcare professionals and research institutions to facilitate clinical trials that explore new treatments and therapies across various therapeutic areas. Leveraging extensive experience in the clinical research landscape, the organization aims to drive meaningful discoveries that enhance the quality of care and contribute to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Norrköping, , Sweden
Malmö, , Sweden
Göteborg, , Sweden
Sundsvall, , Sweden
Lund, , Sweden
Linköping, östergötland, Sweden
Göteborg, , Sweden
Motala, , Sweden
Linköping, , Sweden
Patients applied
Trial Officials
Daniel B Wilhelms, PhD
Principal Investigator
Linkoeping University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported